Archives

  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2021-03
  • 2020-08
  • 2020-07
  • 2020-03
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • br With respect to the

    2022-05-04


    With respect to the differences stated above in the out-come of patients according to tumor laterality, some authors have suggested that colorectal cancer should be divided into right cancer (from the ascending colon to the splenic flex-ure) and left cancer (from the splenic flexure to the rectum). Based on that classification, the 2-year OS was higher than that found for cancer of the colon and rectum, but the 5-year OS was similar. Our findings were different from those of other international studies in which OS of patients with cancer of the right colon was lower,50,53-56 which has also been debated in light of findings in other cohorts57-60 that, like our study, reported the same OS for the tumors on both sides and even a better survival rate for tumors on the left side. 
    The main strength of the present study was its sizable number of patients, being the second largest Colombian case series after the study by Bohórquez et al,9 and its main weak-ness was the fact that certain data were not reported in the medical records, a common failing in descriptive stud-ies. We were able to show that the patients were similar to those evaluated in both national and international studies, that their management followed the guidelines established by different medical societies, and that patient survival was lower than that observed in developed countries, most likely because Colombia is a county lacking in resources and there-fore access to healthcare services is difficult in some cases. It was concluded that screening strategies as stipulated in the different guidelines, as well as the Colombian ones,61 must be strengthened, given their beneficial impact in rela-tion to colorectal cancer deaths. Detection at earlier stages of the disease will result in lower recurrence and mortality rates.62
    Financial disclosure
    No specific grants were received from public sector agen-cies, the business sector, or non-profit organizations in relation to this study.
    Ethical disclosures
    Protection of human and animal subjects. The authors declare that no experiments were performed on humans or animals for this study.
    Confidentiality of data. The authors declare that they Ko 143 have followed the protocols of their work center on the publica-tion of patient data.
    Right to privacy and informed consent. The authors declare that no patient data appear in blending article.
    Conflict of interest
    The authors declare that there is no conflict of interest.
    References
    5. Montenegro YM, Ramírez AT, Munetón˜ CM, et al. Compor-tamiento del cáncer colorrectal en pacientes menores de cuarenta anos˜ del Hospital Universitario Hernando Moncaleano Perdomo de Neiva (HUHMP) y el Hospital Universitario San Vicente de Paul de Medellín (HUSVP) entre 1980 y 2000. Rev Colomb Cir. 2002;17:10-4.
    Colorectal cancer survival at an oncologic center in Colombia. A historic cohort 183
    6. Barrero DC, Cortés E, Rodríguez Ko 143 C, et al. Características epi-demiológicas y clínicas del cáncer colorrectal en pacientes de la ciudad de Ibagué durante el período 2000-2006. Rev Col Gas-troenterol. 2008;23:315-26.
    7. Ferreira EJ, Meléndez HJ. Características clínicas, demográfi-cas e histopatológicas de los pacientes con cáncer colorrectal del Hospital Universitario de Santander. Rev Colomb Cir. 2012;27:213-20.
    8. Saavedra MA, Guerrero Villota A, López DM, et al. Caracteri-zación de los pacientes diagnosticados con cáncer colorrectal en el periodo 2010-2012 en Hematooncólogos S.A. Rev Colomb Cancerol. 2013;17:176.
    9. Bohórquez M, Sahasrabudhe R, Criollo A, et al. Clinical manifestations of colorectal cancer patients from a large mul-ticenter study in Colombia. Medicine (Baltimore). 2016;95: e4883.
    18. Vilorio Marqués L, Molina AJ, Diez Tascón C, et al. Caracterís-ticas clínicas, anatomopatológicas y moleculares en casos de cáncer colorrectal según localización tumoral y grado de difer-enciación. Rev Colomb Cancerol. 2015;19:193-203.
    24. Cancer Facts & Figures for Hispanics/Latinos 2015-2017. Atlanta, Georgia: American Cancer Society; 2015 [accessed 20 Sep 17]. Available from: https://www. cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-facts-and-figures-for-hispanics-and- 
    latinos/cancer-facts-and-figures-for-hispanics-and-latinos-2015-2017.pdf
    30. Robsahm TE, Aagnes B, Hjartaker A, et al. Body mass index, physical activity, and colorectal cancer by anatomical subsites: A systematic review and meta-analysis of cohort studies. Eur J Cancer Prev. 2013;22:492-505.
    31. Del Giudice ME, Vella ET, Hey A, et al. Systematic review of clinical features of suspected colorectal cancer in primary care. Can Fam Physician. 2014;60:e405-15.